Blood-Based Liquid Biopsy of Circulating Tumour DNA to Achieve Genomic Diagnosis for Glioma
Biomarker Insights · 2026-11 · 21
DOI: 10.1177/11772719261508533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomarker Insights, online erschienen am 17.11.2026. Verfasst von Kieran W. Benn und 4 weiteren Autor:innen. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liquid biopsy of circulating tumour DNA (ctDNA) facilitates genomic diagnosis and influences treatment decisions in many solid organ malignancies. However, its use in glioma, the most common primary brain tumour, has been limited to date. This is likely due to low concentration of tumour analytes within the plasma, assay heterogeneity, and lack of standardisation across studies thus far. While cerebrospinal fluid (CSF) contains greater concentrations of ctDNA than the peripheral circulation, repeated lumbar puncture is not clinically practical for longitudinal monitoring, and may be contraindicated in some patients. Comparatively, blood draw is minimally invasive, can be performed in almost all clinical settings, and is widely accepted as a screening modality by patients already. This narrative review discusses the current state of blood-based liquid biopsy in glioma, in addition to how this may influence clinical decision making and alter patient trajectories.
Zitieren
APA
Benn, K. W., Jones, J. J., Nguyen, H. P. T., French, C. R., & Morokoff, A. P. (2026). Blood-Based Liquid Biopsy of Circulating Tumour DNA to Achieve Genomic Diagnosis for Glioma. Biomarker Insights, 21. https://doi.org/10.1177/11772719261508533
Vancouver
Benn KW, Jones JJ, Nguyen HPT, French CR, Morokoff AP. Blood-Based Liquid Biopsy of Circulating Tumour DNA to Achieve Genomic Diagnosis for Glioma. Biomarker Insights. 2026;21. doi:10.1177/11772719261508533
BibTeX
@article{Benn2026,
author = {Benn, Kieran W. and Jones, Jordan J. and Nguyen, Hong P. T. and French, Christopher R. and Morokoff, Andrew P.},
title = {Blood-Based Liquid Biopsy of Circulating Tumour DNA to Achieve Genomic Diagnosis for Glioma},
journal = {Biomarker Insights},
year = {2026},
volume = {21},
doi = {10.1177/11772719261508533}
}
EUVIMED